The counter opened at Rs 609.85 and touched an intraday high and low of Rs 614.15 and Rs 604.55, respectively, in the session so far. The stock of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 647.9 and a 52-week low of Rs 397.3.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 35888.74 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 6499.78 crore for the quarter ended 31-Dec-2022, up 12.13 per cent from previous quarter's Rs 5796.56 crore and up 7.13 per cent from the year-ago quarter's Rs 6067.21 crore.
The net profit for latest quarter stood at Rs 491.26 crore, down 18.76 per cent from the same quarter a year ago.
As of 31-Mar-2023, domestic institutional investors held 7.64 per cent stake in the firm, while foreign institutional investors held 23.03 per cent and the promoters 51.83 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 17.96 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price